Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: New Insights into PBMC Mitochondrial Responses Using Fluorespirometry
Published on: May 24, 2024
Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered
Vasile Mihai Sularea1, Liam Townsend2,3, Cian Reid1
1School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Long COVID (LC) patients show immune cell mitochondrial dysfunction and altered cytokine production linked to symptom severity. These findings suggest potential biomarkers and therapeutic targets for post-COVID conditions.
Area of Science:
- Immunology
- Mitochondrial Biology
- Virology
Background:
- Postacute sequelae of SARS-CoV-2 infection (long COVID) is a complex condition with poorly understood pathology.
- Metabolic dysregulations are described in long COVID, but immune cell immunometabolic alterations remain unclear.
Purpose of the Study:
- To investigate immunometabolic alterations in circulating immune cells of long COVID patients.
- To correlate immune cell mitochondrial function and cytokine responses with long COVID symptom severity.
Main Methods:
- Clinical, immunologic, and mitochondrial analyses were performed on 27 long COVID patients and 27 healthy controls.
- Mitochondrial function (mass, membrane potential) in lymphocytes and monocytes was assessed.
- Cytokine production (IFN-γ, IFN-β, IL-10) after stimulation was measured using multiplex immunoassay.
Main Results:
- Long COVID patients reported significant symptom burden compared to their pre-infection state.
- Decreased mitochondrial membrane potential was observed in CD56bright natural killer cells (dizziness) and CD4+ lymphocytes (breathlessness).
- Impaired IFN-γ production post-LPS stimulation and reduced IFN-β/IL-10 responses post-R848 stimulation were associated with specific symptoms.
Conclusions:
- Symptom severity in long COVID is linked to mitochondrial dysfunction in immune cells.
- Altered cytokine responses in long COVID patients may serve as potential disease biomarkers.
- These findings highlight potential targets for future therapeutic strategies in long COVID management.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

